Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

01-Aug-18 - 30-Jul-19
Buy Ratio:35%

Up

# Net Buyers:103
# Net Sellers:189

Previous 52 Weeks

02-Aug-17 - 31-Jul-18
Buy Ratio:33%
# Net Buyers:100
# Net Sellers:206
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Juno Therapeutics, Inc.--$1.28B  
Kite Pharma, Inc.--$688.62M  
Corium International, Inc.$297.94M$301.77M  
Sucampo Pharmaceuticals, Inc.--$209.03M  
Madrigal Pharmaceuticals, Inc.$1.22M$140.42M  
New Net Buyers
CompanyNet Buy AmountChange
Corium International, Inc.$297.94M$301.77M  
Madrigal Pharmaceuticals, Inc.$1.22M$140.42M  
Acadia Pharmaceuticals Inc$22.45M$31.36M  
Galectin Therapeutics Inc$19.82M$30.61M  
Alder Biopharmaceuticals Inc$17.77M$19.98M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Tesaro, Inc.($3.37B)($3.38B)  
Osiris Therapeutics, Inc.($281.65M)($281.65M)  
Seattle Genetics Inc /wa($27.14M)($275.65M)  
Mirati Therapeutics, Inc.($232.36M)($224.76M)  
Eli Lilly & Co($483.52M)($223.78M)  
New Net Sellers
CompanyNet Buy AmountChange
Tesaro, Inc.($3.37B)($3.38B)  
Seattle Genetics Inc /wa($27.14M)($275.65M)  
Intercept Pharmaceuticals, Inc.($83.40M)($96.74M)  
Immune Design Corp.($42.92M)($54.56M)  
la Jolla Pharmaceutical Co($4.61M)($53.32M)